Facebook
X
LinkedIn
ForwardRadiation Therapy for Sarcomas - Best Practices and Current Trends 2025
This activity reviews the literature for key aspects of soft tissue sarcoma management in adults. The goal is to provide an evidence base to guide clinicians on practice for management of these rare tumors.
This activity is available from August 4, 2025, through 11:59 p.m. Eastern time on March 1, 2026.
This activity was originally presented and recorded at the 2025 ASTRO Annual Refresher Course.
Target Audience
The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, medical physicists, and radiation dosimetrists.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Understand the rationale for combined modality local therapy for soft tissue sarcomas (STS).
- Understand the risk and benefits of preoperative vs. postoperative radiation therapy and radiotherapy planning considerations for both.
- Understand the current state of the data regarding hypofractionation for STS.
Faculty:
B. Ashleigh Guadagnolo, MD, is employed by MD Anderson Cancer Center and has no relevant financial relationships with ineligible companies.
Planners:
Michael Haddock, MD, is employed by Mayo Clinic Rochester and has no relevant financial relationships with ineligible companies.
William Small, MD, is employed by Loyola University Chicago. Dr. Small serves on a Data Safety Monitoring Board for Novocure and a Speaker's Bureau for Zeiss.
Parul Barry, MD, is employed by University of Pittsburgh Medical Center. Dr. Barry receives grant/research funding from Silverlon.
Salma Jabbour, MD, is employed by Rutgers University. Dr. Jabbour receives grant/research funding from Merck and Beigene and serves as a consultant for Radiologica and MX Medical.
Malcom Mattes, MD, is employed by Rutgers Cancer Institute. Dr. Mattes receives grant/research funding from Gilead Sciences.
Manisha Palta, MD, is employed by Duke Cancer Institute. Dr. Palta receives grant/research funding from Merck and Varian Medical Systems.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.25 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- 1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $149
- Member: $99
- Member-in-Training: $49
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until March 1, 2026, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.